We have participated in Cancer Research Trials since June of 1986 and we are proud that our first patient is still living today! Since 1986, we have entered over 500 patients in clinical trials. These trials lead to new FDA approvals, for drugs such as Taxol, Herceptin, Afinitor, and Duvelisib.
We participate in clinical trials through the Mayo Clinic via the Academic Community Cancer Research United Group, Alliance Foundation Trials, Sarah Cannon Research Institute, The National Cancer Institute via the University of Oklahoma, and various pharmaceutical trials.
As a person who has been diagnosed with cancer, you should be well informed. You may have several treatment choices. It is important to learn about your options. One choice you may have is a cancer clinical trial. If you are interested in participating in a clinical trial, consult with your physician. Please note: clinical trials are not risk-free. Patients must explore the options that are best for their individual needs with the help of their physician.
Trials we participate in are Phase II and Phase III, no Phase 1. Examples of trials we have participated in are: Brain, Breast, Carcinoid, Colon, Gastric, Head and Neck, Leukemia, Lung, Lymphoma, Melanoma, Myeloma, Ovarian, Prostate, Rectal, Renal, Sarcoma, and Prostate Prevention. We also participate in Biospecimen protocols, registries, and quality of life studies.